BiologicalDrug
HB0017 clinical trials
Also written HB0017.
How studies write it
Studies that test it under each name
Development codes
- HB0017
- 3
Studies by the year they started
4 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Huabo Biopharm Co., Ltd. (4)
Studies
Open first, then newest update. How each study uses HB0017 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Phase 2 Study of HB0017 in Psoriasis PatientsCompletedPhase 2Huabo Biopharm Co., Ltd.NCT06592274Written as HB0017
- Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisCompletedPhase 3Huabo Biopharm Co., Ltd.NCT06477237Written as HB0017 Q4W
- A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisCompletedPhase 2Huabo Biopharm Co., Ltd.NCT05531682Written as HB0017
- A Study of Injection HB0017 in Adult Healthy VolunteersCompletedPhase 1Huabo Biopharm Co., Ltd.NCT04505033Written as HB0017